首页> 外国专利> Novel Biomarker for Diagnosis of Anticancer drug Resistance of Biliary tract Cancer and Uses thereof

Novel Biomarker for Diagnosis of Anticancer drug Resistance of Biliary tract Cancer and Uses thereof

机译:新型的胆道癌抗药性诊断生物标志物及其应用

摘要

The present invention provides novel molecular markers for the anticancer drug resistance of bile duct cancer and its diagnostic and therapeutic uses. The marker of the present invention is significantly increased in the anticancer drug resistant biliary cancer cell line as comd to the anti-cancer drug resistant biliary cancer cell line. By inhibiting the expression of the marker protein of the present invention, the susceptibility of the anticancer drug resistant biliary tract to the anticancer drug can be improved.;
机译:本发明提供了用于胆管癌的抗癌药耐药性及其诊断和治疗用途的新型分子标记。与抗癌药性胆汁癌细胞系相比,本发明的标记在抗癌药性胆汁癌细胞系中显着增加。通过抑制本发明的标志物蛋白的表达,可以提高抗癌药抗性胆道对抗癌药的敏感性。

著录项

  • 公开/公告号KR101888022B1

    专利类型

  • 公开/公告日2018-08-14

    原文格式PDF

  • 申请/专利权人 코웰바이오다임 주식회사;

    申请/专利号KR20160066719

  • 发明设计人 송시영;박수빈;

    申请日2016-05-30

  • 分类号G01N33/574;A61K31/517;A61K31/7088;A61K39/395;C12N15/115;C12Q1/68;

  • 国家 KR

  • 入库时间 2022-08-21 12:37:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号